Deflin Gayle has filed 9 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 5122 shares of Amphastar Pharmaceuticals, Inc. ($AMPH) on June 02, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 2, 2025 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Not found | A | Common Stock | 5122 | $0.00 | 10,914.0000 | 49,890,000 | 88.43% | 0.01% |
| June 2, 2025 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Not found | A | Stock Option (right to buy) | 11402 | $0.00 | 11,402.0000 | 49,890,000 | 9999.99% | 0.02% |
| June 3, 2024 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Not found | A | Common Stock | 3076 | $0.00 | 5,792.0000 | 53,013,000 | 113.25% | 0.01% |
| June 3, 2024 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Not found | A | Stock Option (right to buy) | 6864 | $0.00 | 6,864.0000 | 53,013,000 | 9999.99% | 0.01% |
| Nov. 14, 2023 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Director | S | Common Stock | 4163 | $55.45 | 2,716.0000 | 53,921,000 | 60.52% | 0.01% |
| June 5, 2023 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Director | A | Common Stock | 2716 | $0.00 | 6,879.0000 | 51,970,000 | 65.24% | 0.01% |
| June 5, 2023 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Director | A | Stock Option (right to buy) | 7016 | $0.00 | 7,016.0000 | 51,970,000 | 9999.99% | 0.01% |
| May 18, 2023 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Director | S | Common Stock | 4519 | $44.01 | 4,163.0000 | 51,970,000 | 52.05% | 0.01% |
| May 15, 2023 | Amphastar Pharmaceuticals, Inc. | $AMPH | Deflin Gayle | Director | S | Common Stock | 1500 | $43.15 | 8,682.0000 | 51,970,000 | 14.73% | 0.00% |